Over the years, awareness of breast cancer (its early detection, risk factors and so forth) has made great strides. There has been a progressively decreasing incidence rate of breast cancer each year, especially after the year 2000. This was considered to be due to the decline in hormone therapy use after the Women’s Health Initiative Study reported the high risk of breast cancer (and other diseases) with hormone therapy use. And with early detection as well as advances in available treatment, both conventional and natural, breast cancer survivors in the Unites States now number more than 2.8 million.
Risk Factors and Precursors of Breast Cancer
Besides gender (more women than men) and family history (having a first degree relative with breast cancer), there are other factors that increase the risk of developing breast cancer.
Dense Breast Tissue
Some studies have shown that the risk for breast cancer is up to 5 times greater in women with dense breast tissue. In California, Senate Bill 791 was put into effect in April 2012 requiring laboratories and doctors to inform patients if dense breast tissue is found in a mammogram, as this signals a risk for breast cancer.
Benign Breast Conditions
Even benign conditions like fibrocystic breasts, breast calcifications and benign tumors increase the risk for breast cancer. Although there is still controversy over it, some studies show that small clusters of breast calcification is an early warning sign of breast cancer and should be treated immediately.
Oral contraceptives contain estradiol or progesterone, or both. These hormones are both associated with breast cancer risk.Hormone Therapy, especially after menopause
There is no disputing the fact that hormones, especially estrogen, play a role in the development of breast cancer. The Women’s Health Initiative study was one of the first large-scale study to bring that fact into light. Now we know that hormones, especially estrogen, fuel cell proliferation. Being on hormone replacement therapy (HRT or BHRT) increases the chances of abnormal breast growths.Obesity
For premenopausal women, the ovaries are the main source of estrogen. After menopause, fat tissue becomes the largest source of estrogen. Fat tissue has a high concentration of aromatase, which fuels more estrogen production. Studies show that estrogen level in postmenopausal obese women is 50 to 100 times higher than normal-weight counterparts. Currently, 1 in 8 women will develop breast cancer in their lifetime. For postmenopausal women, this increases in age up to 1 in 6 women past age 80.
Natural Therapies for Breast Cancer
“I felt like my world came crashing down on me.” That seems to be a common reaction by individuals diagnosed with breast cancer. Don’t let it be a death sentence. There are many options for you out there, both conventional and natural. There are also many support groups that can guide you through each step as you fight this battle.
What we are going to explore now are natural therapies and how they would be applicable for breast cancer.
Myomin Addresses the Hormonal Aspect of Breast Cancer
There are 4 types of breast cancer. Two of these types are hormonal in nature: Estrogen Receptor Positive (ER+) and Progesterone Receptor Postivie (PR+). Statistics show that 2 out of 3 breast cancer cases are hormone receptor positive.
Myomin would help manage hormone-receptor positive breast cancers so that estrogen and progesterone do not fuel the growth of abnormal breast tissue.
Studies have already illustrated that Myomin successfully reduces estradiol and helps manage the growth of estrogen-responsive tissue through its aromatase reduction function.
Angiostop Inhibits Angiogenesis and Receptor Tyrosine Kinases (RTKs) in Breast Cancer
The other two types of breast cancer are HER-2 Positive (HER2+) and Triple Negative. In both these types, certain growth factors are overexpressed. Angiostop is a natural targeted therapy supplement from a special sea cucumber extract. It inhibits 4 different growth factor receptors or RTKsoverexpressed in cancer. For breast cancer, in particular, it inhibits the following:
By inhibiting VEGFR, EGFR and FGFR, Angiostop is able to stop angiogenesis (new blood vessel formation) from the tumor, proliferation, invasion and metastasis. Furthermore, it induces apoptosis (natural cell death) of cancer cells.
During the month of October, K6 Wellness is offering 15% off all regularly priced CHI products. Stock up on your supplements while they are on sale!
Contact our office if you would like to order these products. At K6 Wellness Center, we are here to help you on your journey to good health. Please feel free to ask a question or leave a comment.
*article from Dr. Chi at Chi Health